Living with Parkinson’s disease often feels like a race against the clock. Patients frequently battle "off" periods—those frustrating times when standard medications wear off and symptoms like tremors, stiffness, and slowness return.
If you or a loved one are seeking better control over these symptoms, you likely heard about Crexont. Approved by the FDA in August 2024, Crexont is a breakthrough extended-release oral formulation of carbidopa/levodopa designed to provide more "on" time with fewer daily doses. However, in 2026, many patients are still facing pharmacy-level shortages and limited availability worldwide.
I am a USA Dr., and today I’m sharing how the MyUSADr. telehealth platform is bridging the gap, allowing patients globally to access top-tier US neurology expertise and the latest therapeutic options.
What Makes Crexont Different?
Unlike traditional immediate-release medications that may require dosing five or more times a day, Crexont (manufactured by Amneal Pharmaceuticals) uses a unique combination of immediate-release granules and extended-release pellets.
According to clinical data highlighted by the Michael J. Fox Foundation, this design can provide:
- Extended "Good On" Time: Patients often gain significantly more hours of symptom control.
- Simplified Schedules: Achieving better results with just three doses per day is a reality for many.
- Targeted Absorption: A mucoadhesive polymer helps the medication stay in the absorption area longer.
Despite these benefits, finding a local doctor who is comfortable with the complex dosing conversion or finding a pharmacy that stocks it remains a hurdle.
Why Get a Neurology Second Opinion from MyUSADr.?
Neurological conditions like Parkinson’s, Multiple Sclerosis, and Epilepsy require precision. A second opinion isn’t just a "second look"—it’s a specialized strategy to optimize your life.
1. Expert Guidance on New Treatments
Our American Board-Certified Neurologists are actively practicing in the US and are among the first to implement new protocols. They can evaluate your specific case to determine if you are a candidate for Crexont and provide the necessary dosing logic to transition from your current meds safely.
2. Overcoming Shortages and Access Barriers
If you are facing local medication shortages, a MyUSADr. specialist can suggest alternative US-standard protocols or therapeutic equivalents based on the latest NINDS guidelines. We provide a comprehensive report that acts as a roadmap for your local physician.
3. Reliable, Cost-Effective, and Easy
Traveling to the US for a world-class consultation can cost thousands. With MyUSADr., you get the same level of expertise for a fraction of the cost:
- No Travel Required: Secure consultations from anywhere in the world.
- Rapid Turnaround: Receive your expert report in just 3–5 business days.
- Affordable Access: Transparent pricing starting with a low initial review fee.
How MyUSADr. Works
- Submit Your Records: Use our secure platform to upload your history and imaging.
- Expert Review: A US specialist reviews your data with an objective, expert lens.
- Receive Your Report: Get a detailed medical opinion, treatment alternatives, and the peace of mind you deserve.
Take Control of Your Treatment Today
Don't let "off" periods dictate your schedule. Whether you are interested in Crexont or need a total review of your neurological health, our specialists are ready.